Pluristem’s PLX Cells May Effectively Treat Ischemic Stroke - Brain Research Journal Reports
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that the results of a pre-clinical study in an animal model of ischemic stroke demonstrated that its PLacental eXpanded (PLX) cell therapy may be an effective treatment for this disorder. Results will be published in the journal Brain Research (Brain Research, Feb. 22, Vol…
More: continued here
Filed under: Neurology / Neuroscience on February 6th, 2010
You must be logged in to post a comment.